Companies › MLYS

MINERALYS THERAPEUTICS INC (MLYS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001933414 · EDGAR filings · Updated 2026-07-23

MINERALYS THERAPEUTICS INC (MLYS) has reported institutional ownership of 109.6%, with 214 institutional managers holding positions valued at $2.46B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-23 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Notice of proposed sale filed (Form 144)
• 2026-07-20 — Insider transaction reported (Form 4)
• 2026-07-17 — Notice of proposed sale filed (Form 144)
• 2026-07-15 — Insider transaction reported (Form 4)
• 2026-07-15 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MINERALYS THERAPEUTICS INC has 214 institutional holders and institutional ownership of 109.6%.

Insider activity

Insiders reported 129 transactions (5 buys, 71 sells) across 14 reporting insiders, with a net reported value of −$20.5M.

Related companies

PRIVIA HEALTH GROUP INC (PRVA) · NATIONAL VISION HLDGS INC COM (EYE) · DENTSPLY SIRONA INC (XRAY) · ENLIVEN THERAPEUTICS INC (ELVN) · VIKING THERAPEUTICS INC (VKTX) · LEMAITRE VASCULAR INC (LMAT)